Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...
Teladoc Health faces pressure in a saturated telehealth market, but it's hard to ignore the virtual care company's massive ...
Yesterday, spots of pink could be spotted on the streets of San Francisco, and it wasn’t a coincidence. Members of the ...
JPMorgan shut down an internal comment thread after its five-day-a-week mandate drew more than 300 comments from staff. ‘This ...
JPMorgan Chase & Co. is preparing to tell all its employees to return to the office five days a week, ending a hybrid-work option for thousands of staff and returning to the attendance policy that was ...
It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...
The Westin St. Francis, site of the JP Morgan Healthcare Conference in San Francisco, California. With another JP Morgan in the rearview mirror, it’s time to take stock of the announcements ...
JPMorgan Chase on Wednesday posted record annual profit as its dealmakers and traders reaped a windfall from rebounding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback